Loading stock data…
Advanced Biomed Inc (ADVB)
$4.50+0.01 (+0.22%)
Market OpenUpdated 1:34 PM EDT
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Advanced Biomed Inc. in the Healthcare sector is trading at $4.50 with a market capitalization of $8M. The stock is currently near its 52-week low of $3.61, remaining 30.7% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | — | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$519,836↓ | -$396,642↑ | -$523,914 | — | -$567,507 |
| Net Income | -$488,942↓ | $6.86M↑ | -$386,901 | — | -$1.38M |
Peer Comparison
JNJUNHPFE
Fundamentals
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample pre...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$7.68M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
49.93%
Volume
Today's trading volume
29,064
